Author

Hanna Retallack

Primary ORCID profile (0000-0003-0533-9102 · 5 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Hanna RetallackiD5 papers · University of California, San Francisco

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:deconvolution· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Alex A. Pollen· 1 shared Arnold R. Kriegstein· 1 shared Brian D O'Donovan· 1 shared Carmen Sandoval-Espinosa· 1 shared Carolina Arias· 1 shared Elizabeth Di Lullo· 1 shared Emily D Crawford· 1 shared Eric D Chow· 1 shared

Activity by Year

2015-2016 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Alex A. Pollen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Zika Virus in the Human Placenta and Developing Brain: Cell Tropism and Drug Inhibition

Hanna Retallack, Elizabeth Di Lullo, Carolina Arias, Kristeene A. Knopp, Carmen Sandoval-Espinosa, Matthew T. Laurie, Yan Zhou, Matthew Gormley, Walter R. Mancia Leon, Robert Krencik, Erik M. Ullian, Julien Spatazza, Alex A. Pollen, Katherine Ona, Tomasz J. Nowakowski, , Arnold R. Kriegstein

This study identifies ZIKV susceptible cell types in placenta and brain, shows antibiotic inhibition of viral proliferation, and suggests mechanisms for congenital ZIKV pathologies.

bioRxiv · Jun 15, 2016 · PreprintCell Biology

Depletion of Abundant Sequences by Hybridization (DASH): Using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications

Wei Gu, Emily D Crawford, Brian D O'Donovan, Michael R Wilson, Eric D Chow, Hanna Retallack, Joseph L DeRisi

DASH uses Cas9 to deplete high-abundance sequences in sequencing libraries, improving detection of low-abundance targets in various applications.

bioRxiv · Nov 20, 2015Genomics